Vaccine Against Ebola in Sight
Immunization Possible With Just One Injection
A live vaccine based on the "Vesicular Stomatitis Virus" (VSV) has yielded highly promising results for the rapid development of an effective vaccine against the Ebola virus. This vaccine would only need to be injected once for long-lasting immunoprotection. These are the key findings of an international study coordinated by the World Health Organisation (WHO) in which the MedUni Vienna also played an important role. In this context, Markus Müller, Vice Rector for Research and Head of the University Department of Pharmacology, is acting within the VEBCON study consortium as head of the "Data Safety Monitoring Board" and is therefore jointly responsible for checking the vaccine's safety.
Read more on this topic here
Agnandji S. T. et al.: Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe - Preliminary Report. NEJM, April 1, 2015. DOI: 10.1056/NEJMoa1502924.